Press release
Prominent Angiotensin Receptor Blockers (ARBs) Market Trend for 2025: Innovative Product Solution In The Angiotensin Receptor Blockers Market
Angiotensin Receptor Blockers (ARBs) Market
The upward trend of cardiovascular diseases is predicted to fuel advancements in the angiotensin receptor blockers market. Often related to the accumulation of fatty components within the arteries (atherosclerosis) and heightened probability of blood clots, cardiovascular disease (CVD) influences the heart or blood vessels. The function of angiotensin receptor blockers is to alleviate blood pressure and enhance the heart's blood pumping ability by aiding in the relaxation of veins and arteries, thereby potentially reducing the threat of cardiovascular disease. For instance, the American College of Cardiology, a professional medical organization based in the US, revealed in August 2022 that the projected rates of heart-related risks and diseases are set to significantly rise in the United States by 2060. Consequently, the surging occurrence of cardiovascular diseases is encouraging the expansion of the angiotensin receptor blockers market.
Get Your Angiotensin Receptor Blockers (ARBs) Market Report Here:
https://www.thebusinessresearchcompany.com/report/angiotensin-receptor-blockers-arbs-global-market-report
How will the growth rate of the angiotensin receptor blockers (arbs) market shape industry trends by 2034?
In recent times, the angiotensin receptor blockers (ARBs) market has experienced consistent growth. The market is set to expand from $8.51 billion in 2024 to $8.87 billion in 2025, achieving a compound annual growth rate (CAGR) of 4.1%. The drivers of growth during the historic period include factors such as the hypertension epidemic, effective clinical results, the burden of cardiovascular diseases, renal protection, established clinical guidelines, the prescription of ARBs as the primary approach to treatment, and their cost-effectiveness.
The market for angiotensin receptor blockers (ARBs) is projected to exhibit consistent expansion in the upcoming years, reaching $10.76 billion by 2029 with a compound annual growth rate (CAGR) of 5.0%. This progression during the forecast period can be linked to various factors like precision medicine methodologies, increased attention on combination therapies, the worldwide market extension, approaches based on biomarker treatments, governmental initiatives, and heightened hypertension awareness. Key trends expected to shape the forecast period are the uptake of telemedicine, investment in research and improvement, competition from generics and patent expirations, digital health aids for medication compliance, and rivalry from biosimilars.
Get Your Free Sample Now - Explore Exclusive Market Insights:
https://www.thebusinessresearchcompany.com/sample.aspx?id=8943&type=smp
What trends are poised to drive the future success of the angiotensin receptor blockers (arbs) market?
Companies at the forefront of the angiotensin receptor blocker market are making strides in product advancement, such as creating angiotensin receptor neprilysin inhibitors, to broaden treatment possibilities and increase positive patient results for those dealing with cardiovascular diseases. Angiotensin receptor neprilysin inhibitors (ARNIs) constitute a category of drugs utilized in managing heart failure. For example, Glenmark Pharmaceuticals, a pharmaceutical corporation based in India, rolled out sacubitril + valsartan tablets in January 2023. These tablets are specifically designed to deal with heart failure, more specifically, heart failure with a reduced ejection fraction (HFrEF). The tools used in this therapy category are known as ARNI. Sacubitril boosts the natriuretic peptide (NP) scheme, which assists with fluid overload relief and encourages blood vessel expansion, whereas valsartan inhibits the renin-angiotensin system (RAS) to diminish blood pressure and lighten the heart's work burden. These two components, working in unison, augment heart failure symptom relief, mitigate the risk of cardiovascular death, and reduce the probability of heart failure-related hospitalizations. This treatment combination is commercially available under the brand name Sacu V.
Which primary segments of the angiotensin receptor blockers (arbs) market are driving growth and industry transformations?
The angiotensin receptor blockers (ARBs) market covered in this report is segmented -
1) By Product: Valsartan, Telmisartan, Losartan, Irbesartan, Azilsartan, Olmesartan
2) By Application: Hypertension, Cardiovascular Diseases, Kidney Diseases, Other Applications
3) By End User: Hospitals, Specialty Clinics, Ambulatory Surgical Centers
Subsegments:
1) By Valsartan: Tablets, Capsules, Injectable Forms
2) By Telmisartan: Tablets, Capsules
3) By Losartan: Tablets, Oral Solution
4) By Irbesartan: Tablets, Oral Solution
5) By Azilsartan: Tablets
6) By Olmesartan: Tablets, Oral Suspension
Unlock Exclusive Market Insights - Purchase Your Research Report Now!
https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=8943
Which geographical regions are pioneering growth in the angiotensin receptor blockers (arbs) market?
North America was the largest region in the angiotensin receptor blockers (ARBs) market share in 2024. The regions covered in the angiotensin receptor blockers (ARBs) market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa
Who are the influential players reshaping the angiotensin receptor blockers (arbs) market landscape?
Major companies operating in the angiotensin receptor blockers (ARBs) market include Pfizer Inc., Novartis AG, Merck & Co. Inc., AstraZeneca Plc., Bristol-Myers Squibb Company, GlaxoSmithKline plc, Teva Pharmaceutical Industries Ltd., Daiichi Sankyo Company Limited, Lupin Limited, Dr. Reddy's Laboratories Ltd., Takeda Pharmaceutical Company Limited, Thermo Fisher Scientific, Sanofi, Johnson & Johnson, Eli Lilly, Bayer AG, Abbvie Inc., Mylan N.V., Sun Pharmaceutical Industries Ltd., Torrent Pharmaceuticals Ltd., Zydus Cadila, Glenmark Pharmaceuticals Ltd., Cipla Ltd., Hikma Pharmaceuticals PLC, Amneal Pharmaceuticals LLC, Zhejiang Huahai Pharmaceutical Co. Ltd., Boehringer Ingelheim Ltd., Astellas Pharma
Customize Your Report - Get Tailored Market Insights!
https://www.thebusinessresearchcompany.com/sample.aspx?id=8943&type=smp
What Is Covered In The Angiotensin Receptor Blockers (ARBs) Global Market Report?
• Market Size Forecast: Examine the angiotensin receptor blockers (arbs) market size across key regions, countries, product categories, and applications.
• Segmentation Insights: Identify and classify subsegments within the angiotensin receptor blockers (arbs) market for a structured understanding.
• Key Players Overview: Analyze major players in the angiotensin receptor blockers (arbs) market, including their market value, share, and competitive positioning.
• Growth Trends Exploration: Assess individual growth patterns and future opportunities in the angiotensin receptor blockers (arbs) market.
• Segment Contributions: Evaluate how different segments drive overall growth in the angiotensin receptor blockers (arbs) market.
• Growth Factors: Highlight key drivers and opportunities influencing the expansion of the angiotensin receptor blockers (arbs) market.
• Industry Challenges: Identify potential risks and obstacles affecting the angiotensin receptor blockers (arbs) market.
• Competitive Landscape: Review strategic developments in the angiotensin receptor blockers (arbs) market, including expansions, agreements, and new product launches.
Connect with us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company,
Twitter: https://twitter.com/tbrc_info,
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ.
Contact Us
Europe: +44 207 1930 708,
Asia: +91 88972 63534,
Americas: +1 315 623 0293 or
Email: mailto:info@tbrc.info
Learn More About The Business Research Company
With over 15,000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Our flagship product, the Global Market Model delivers comprehensive and updated forecasts to support informed decision-making.
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Prominent Angiotensin Receptor Blockers (ARBs) Market Trend for 2025: Innovative Product Solution In The Angiotensin Receptor Blockers Market here
News-ID: 3890912 • Views: …
More Releases from The Business Research Company
Foam Tape Industry to Achieve $14.62 Billion Growth by 2029
Get 30% off global market reports with code ONLINE30 and keep ahead of tariffs, macro trends, and worldwide economic developments.
How Will the Foam Tape Market Grow by 2025 in Terms of Size and Growth?
In recent times, there has been significant growth in the market size for foam tape. It is projected to escalate from $10.02 billion in 2024 to $10.77 billion in 2025, demonstrating a compound annual growth rate (CAGR)…
Continuous Positive Airway Pressure (CPAP) Mask Market Expansion Outlook: $3.85 …
Get 30% off global market reports with code ONLINE30 and keep ahead of tariffs, macro trends, and worldwide economic developments.
What Is the Projected CAGR for the Continuous Positive Airway Pressure (CPAP) Mask Market from 2024 to 2025?
In recent times, the market size of the continuous positive airway pressure (cpap) mask has seen robust growth. The market is projected to rise from $2.83 billion in 2024 to $3 billion in 2025,…
Alkyd Coating Market to Record 7.5% CAGR Growth Through 2029 | Global Analysis R …
Use ONLINE30 for 30% savings on global market reports and stay on top of tariff updates, market trends, and economic shifts worldwide.
Alkyd Coating Market Outlook: How is the Market Expected to Grow by 2025?
The market size of alkyd coatings has experienced significant growth in the past few years. The market is projected to expand from $25.13 billion in 2024 to $26.74 billion in 2025, exhibiting a compound annual growth rate…
Water Free Skincare Market Analysis: $22.5 Billion by 2029 With a CAGR of 7%
Stay informed on tariff shifts, macro trends, and global economic changes-use code ONLINE30 to enjoy 30% off our global market reports.
Water Free Skincare Market Value Projection: How Much Will the Market Size by 2025?
The market size of waterless skincare has experienced a robust increase in recent years. The expected growth is from $15.96 billion in 2024 to $17.15 billion in 2025, with a compound annual growth rate (CAGR) of 7.5%.…
More Releases for ARBs
Angiotensin Receptor Blockers (ARBs) Market Size and Forecast
𝐔𝐒𝐀, 𝐍𝐞𝐰 𝐉𝐞𝐫𝐬𝐞𝐲- The global Angiotensin Receptor Blockers (ARBs) Market is expected to record a CAGR of XX.X% from 2024 to 2031 In 2024, the market size is projected to reach a valuation of USD XX.X Billion. By 2031 the valuation is anticipated to reach USD XX.X Billion.
The Angiotensin Receptor Blockers (ARBs) market has been expanding steadily due to their widespread use in the treatment of hypertension, heart failure, and…
Angiotensin Receptor Blockers (ARBs) Market Current Status and Future Prospects …
𝐔𝐒𝐀, 𝐍𝐞𝐰 𝐉𝐞𝐫𝐬𝐞𝐲- The global Angiotensin Receptor Blockers (ARBs) Market is expected to record a CAGR of XX.X% from 2024 to 2031 In 2024, the market size is projected to reach a valuation of USD XX.X Billion. By 2031 the valuation is anticipated to reach USD XX.X Billion.
The impact of manufacturers on the market is significant across various industries, influencing supply chains, consumer choices, and economic growth. Manufacturers are key…
Angiotensin Receptor Blockers (ARBs) Market Trends, Strategies, Size, Share And …
"The Business Research Company has recently revised its global market reports, now incorporating the most current data for 2024 along with projections extending up to 2033.
Angiotensin Receptor Blockers (ARBs) Global Market Report 2024 by The Business Research Company offers comprehensive market insights, empowering businesses with a competitive edge. It includes detailed estimates for numerous segments and sub-segments, providing valuable strategic guidance.
The Market Size Is Expected To Reach $10.28 billion In…
Angiotensin Receptor Blockers (ARBs) Market size, Share, Trends, Drivers And For …
The Business Research Company's global market reports are now updated with the latest market sizing information for the year 2023 and forecasted to 2032
The Business Research Company's Angiotensin Receptor Blockers (ARBs) Global Market Report 2023 identifies the increasing incidence of cardiovascular diseases as the major driver for the angiotensin receptor blockers (ARBs) market's growth in the forecast period. It is frequently associated with the development of fatty deposits within the…
Angiotensin Receptor Blockers (Arbs) Market Size, Share, Growth Report 2023
The global angiotensin receptor blockers (arbs) market size was valued at USD 8,049.9 million in 2022 and is poised to grow at a significant CAGR of 3.9% during the forecast period 2023-29. The primary drivers of the expansion of the global angiotensin receptor blockers market include the increasing prevalence of cardiovascular diseases and chronic kidney disorders. In addition, increasing geriatric population is expected to boost the growth of angiotensin receptor…
Angiotensin Receptor Blockers (ARBs) Market 2022 | Detailed Report
The top-notch information research report published by markets and markets is a vital asset that offers qualitative and quantitative factors of the Angiotensin Receptor Blockers (ARBs) market. The research study and methodologies mentioned in the report examine the critical vendors by considering their contribution to the global market. Furthermore, the report offers an in-depth insight into leading players' performance based on revenue generation and client requirements. Also, the research report…
